TH51248A - The use of pyrimidine derivatives in the prevention and treatment of ischemic stroke. - Google Patents
The use of pyrimidine derivatives in the prevention and treatment of ischemic stroke.Info
- Publication number
- TH51248A TH51248A TH1000071A TH0001000071A TH51248A TH 51248 A TH51248 A TH 51248A TH 1000071 A TH1000071 A TH 1000071A TH 0001000071 A TH0001000071 A TH 0001000071A TH 51248 A TH51248 A TH 51248A
- Authority
- TH
- Thailand
- Prior art keywords
- prevention
- treatment
- pyrimidine derivatives
- formula
- ischemic stroke
- Prior art date
Links
- 229940083082 pyrimidine derivative acting on arteriolar smooth muscle Drugs 0.000 title claims abstract 4
- 150000003230 pyrimidines Chemical class 0.000 title claims abstract 4
- 230000002265 prevention Effects 0.000 title abstract 3
- 208000032382 Ischaemic stroke Diseases 0.000 title 1
- 229940079593 drug Drugs 0.000 claims abstract 4
- 239000003814 drug Substances 0.000 claims abstract 4
- 239000000126 substance Substances 0.000 claims abstract 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 1
- 239000001257 hydrogen Substances 0.000 claims 1
- 229910052739 hydrogen Inorganic materials 0.000 claims 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 1
- 229910052757 nitrogen Inorganic materials 0.000 claims 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims 1
- 239000001301 oxygen Substances 0.000 claims 1
- 229910052760 oxygen Inorganic materials 0.000 claims 1
- 210000004204 blood vessel Anatomy 0.000 abstract 4
- 239000008280 blood Substances 0.000 abstract 2
- 210000004556 brain Anatomy 0.000 abstract 2
- 230000002490 cerebral effect Effects 0.000 abstract 2
- 238000004519 manufacturing process Methods 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 238000006467 substitution reaction Methods 0.000 abstract 2
Abstract
DC60 (12/10/44) การใช้อนุพันธ์ไพริมิดีนตามสูตร I (สูตรเคมี) I, โดยหมู่แทนที่เป็นดังกำหนดในข้อความที่เปิดเผยการประดิษฐ์ และเกลือของสารดังกล่าวซึ่งทนได้ทางสรีรวิทยา ในการผลิตยา สำหรับป้องกันและรักษาภาวะสมองขาด เลือดและหลอดเลือดในสมอง แตกหรืออุดตัน การใช้อนุพันธ์ไพริมิดีนตามสูตร I (สูตรเคมี) I, โดยหมู่แทนที่เป็นดังกำหนดในข้อความที่เปิดเผยการประดิษฐ์ และเกลือของสารดังกล่าวซึ่งทนได้ทางสรีรวิทยา ในการผลิตยา สำหรับป้องกันและรักษาภาวะสมองขาด เลือดและหลอดเลือดในสมอง แตกหรืออุดตัน สิทธิบัตรยา DC60 (12/10/44) Use of pyrimidine derivatives according to formula I (chemical formula) I, with group substitutions as given in the invention disclosures. And its salts, which are physiologically resistant to the manufacture of drugs for the prevention and treatment of cerebral insufficiency. Blood and blood vessels in the brain Cracked or clogged The use of pyrimidine derivatives according to formula I (chemical formula) I, with group substitutions is as given in the invention revealing text. And its salts, which are physiologically resistant to the manufacture of drugs for the prevention and treatment of cerebral insufficiency. Blood and blood vessels in the brain Cracked or clogged drug patent
Claims (1)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TH51248A true TH51248A (en) | 2002-06-06 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE0001899D0 (en) | New compounds | |
| ATE469136T1 (en) | INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 | |
| EP1545483A4 (en) | Non-nucleoside reverse transcriptase inhibitors | |
| IL171977A (en) | Cyclic sulfonamide for inhibition of gamma-secretase, process for its preparation and a pharmaceutical composition comprising the same | |
| NO20055649L (en) | Substituted dihydroquinazoline with antivial properties | |
| MXPA04005156A (en) | Adenosine a2a. | |
| YU7804A (en) | Stable polymorph of flibanserin, technical process for its preparation and the use thereof for preparing medicaments | |
| WO2002088100A3 (en) | Deuterated 3-piperidinopropiophenone and medicaments containing said compounds | |
| ATE361918T1 (en) | 4-(4-METHOXYBENZYL)-N'-(5-NITRO-1,3-THIAZOL-2-YL)UREA AND ITS USE IN THE TREATMENT OF GLYCOGEN SYNTHASE KINASE-3 (GSK3)-ASSOCIATED CONDITIONS | |
| WO2003066594A3 (en) | 3-alkanoylamino-propionic acid derivatives used as inhibitors of integrin avss6 | |
| MA27277A1 (en) | PENTAFLUOROSULFANYL-BENZOYLGUANIDINE, METHOD FOR THE PRODUCTION THEREOF AND ITS USE AS A DRUG OR DIAGNOSTIC AGENT AND DRUG CONTAINING THE SAME | |
| TH51248A (en) | The use of pyrimidine derivatives in the prevention and treatment of ischemic stroke. | |
| HUP0400924A3 (en) | Use of 2,5-dihydroxybenzenesulfphonic acid derivatives in the production of a medicament used to potentiate the effect of other drugs in the treatment of erectile dysfunction | |
| PL357999A1 (en) | Lhrh-antagonists, production and use thereof as medicament | |
| MY146601A (en) | Chemokine receptor antagonists and methods of use therefor | |
| Campbell et al. | Doxazosin, a case history | |
| PL365258A1 (en) | Pharmaceutical composition comprising deramciclane for the treatment of the decline and/or damage of cognitive functions | |
| EP1431294A4 (en) | VASCULAR WALL SELECTIVE ACAT INHIBITOR | |
| DE50303551D1 (en) | Cosmetic for cleansing and care of the skin | |
| PT1572686E (en) | Anthranilic acid amide derivatives and their pharmaceutical use | |
| FR2834885B1 (en) | PROCESS FOR THE TREATMENT, ESPECIALLY COSMETICALLY, OF A SKIN ZONE OF A HUMAN SUBJECT BY A TRAN-EPIDERMIC PATHWAY BY PROJECTING A PRESSURIZED LIQUID | |
| MXPA04000918A (en) | Pramipexol as an anticonvulsive agent. | |
| TH78115A (en) | New compound | |
| TH65074A (en) | A condition treatment method associated with useful p38 kinase and perroolothiazine as a kinase inhibitor. | |
| TH42959A (en) | Chemical compound |